Most daily controller medications suffer from ~50+% misuse and non-compliance, due to the cumbersome nature of operating, dosing and maintaining the devices. Qnovia’s™ technology eliminates these complexities. Our platform facilitates intuitive and efficient pharmaceutical dosing, to significantly increase patient compliance and reduce potential misuse.
Qnovia’s™ device technology is the world’s first truly “fit-in-your-pocket,” aseptically pre-filled, and multi-orientation vibrating mesh nebulizer (VMN), complete with a digital metered dose interface and Bluetooth-enabled mobile app functionality, complemented by a disposable cartridge that requires zero cleaning or maintenance.
Delivering a laminar, non-turbulent aerosol with the right particle characteristics is critical for optimal delivery to the lungs, for local as well as systemic treatments.
The Qnovia™ device platform could be positioned for approval as a combination-drug-medical-device in the below indication areas, potentially driving efficacy, compliance and patient adherence rates to new highs.